VOLT CE Mark Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 300 participants.
Also called NCT06106594
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT06106594
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Austria, Belgium, Czechia, Germany, Netherlands, Spain
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06106594. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-24 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VOLT CE Mark Study
- Condition
- Atrial Arrhythmia
- Condition
- Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06106594- Content hash
ea941d6677c38444c9433eab7da731a8ffd4968347b79110c5937387a2c1df33